Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7504 p645-648
31 May 2008

This section
Reprint   Photocopy

PDF 110K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events

Pages: 645   646   647   648

645 Nearly half want pharmacists to stay in pharmacies Nearly half the people and organisations that commented on the Government’s plans to allow pharmacists to leave pharmacy premises while they are open for business were against the proposal
PJ 2008;280:645
Full Text

645 Pandemic flu legislation changes supported Most of the Government’s proposals to amend medicines legislation in the event of an influenza pandemic are supported by those who responded to its initial consultation on the subject
PJ 2008;280:645
Full Text

645 Nigel Clarke chosen to chair Transitional Committee Nigel Clarke has been appointed chairman of the Transitional Committee that will help with the development of a new professional body for pharmacy
PJ 2008;280:645
Full Text

645 On-call payments adjustment postponed The current structure by which hospital pharmacists receive payment for on-call duties will continue until 31 March 2010, the NHS Staff Council has agreed. The structure, originally agreed under the previous Whitley grading system, pays pharmacists approximately £2,500 per year to contribute to the on-call service
PJ 2008;280:645
Full Text

645 Search for RX Factor The search is on for pharmacists who have the knowledge and charisma to be the faces of pharmacy
PJ 2008;280:645
Full Text



646 NICE advocates diabetes education Every patient with type 2 diabetes should be offered structured education when he or she is diagnosed, the National Institute for Health and Clinical Excellence suggests in updated guidance, published this week
PJ 2008;280:646
Full Text

646 Early insulin in type 2 diabetes beneficial Further evidence that early intensive insulin therapy for newly diagnosed type 2 diabetes patients can help the body’s Β-cells recover and restore blood glucose control emerged this week
PJ 2008;280:646
Full Text

646 Tailored care package fails to improve glycaemic control Some cardiovascular benefits are achieved with an enhanced diabetes care package for UK residents of South Asian origin, but improving glycaemic control remains a major challenge, according to a study published
PJ 2008;280:646
Full Text



647 Trusts’ safety alert responses variable, study shows Huge variation exists across trusts in adopting safety alerts, researchers from York and Cardiff universities have shown
PJ 2008;280:647
Full Text

647 Pilot study demonstrates reduction in medication-related events through pharmacists’ and technicians’ interventions Pharmacists and pharmacy technicians have been shown to make a significant contribution to preventing medication-related events during a one-week pilot study at a busy London hospital
PJ 2008;280:647
Full Text

647 Society offers award for medicines safety A new award that recognises significant contributions to improving medicines safety in Britain is to be offered by The Royal Pharmaceutical Society
PJ 2008;280:647
Full Text



648 Opposition to EU plan to ban medicines repackaging An EC proposal to ban the repackaging of medicines to help stamp out drug counterfeiting has attracted widespread opposition
PJ 2008;280:648
Full Text

648 DoH reminded of pharmacists’ role in helping minority ethnic groups The Department of Health is being reminded of the key role community pharmacists can play in helping to meet the needs of black and minority ethnic (BME) patients in England
PJ 2008;280:648
Full Text

648 PGEU promotes pharmacists’ help with adherence problems Including community pharmacists in multidisciplinary care teams can help patients who have problems adhering to therapy, according to a new policy document from the Pharmaceutical Group of the European Union
PJ 2008;280:648
Full Text

648 Melatonin is launched as a POM for short-term insomnia Pharmacists may be asked to dispense melatonin on prescription for patients with short-term insomnia, following the launch of Circadin melatonin tablets as a prescription-only medicine next week
PJ 2008;280:648
Full Text

Back to Top


©The Pharmaceutical Journal